Vimarsana
Biggest News Aggregation in the World

Page 2 - Pfizer Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Research Today - Breaking & Trending Today

Pfizer 2024 Prize awarded to thirteen young scientists - Vimarsana News

Pfizer 2024 Prize awarded to thirteen young scientists

The prize is awarded for outstanding scientific work in the field of medicine.

Discovery of drug candidate to potentially tackle ER-positive breast cancer - Vimarsana News

Discovery of drug candidate to potentially tackle ER-positive breast cancer

An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Cancer Therapeutics Cooperative Research Centre, have discovered a pre-clinical drug candidate demonstrating anti-tumour activity in

Pfizer halts trial for twice a day weight loss drug: What triggered this and how does this affect the user? - Vimarsana News

Pfizer halts trial for twice a day weight loss drug: What triggered this and how does this affect the user?

Once a day pill to continue as Semaglutide flies off shelves

Pfizer's $3.5B cuts may lead to layoffs at Connecticut facility - Vimarsana News

Pfizer's $3.5B cuts may lead to layoffs at Connecticut facility

Layoffs are possibly on the horizon at Pfizer's research facility in Groton, as it launches a company-wide "cost realignment program."

Source: fox61.com
Why Is Pfizer Stock Trading Lower Today After Dropping Obesity Candidate Data? - Pfizer (NYSE:PFE) - Vimarsana News

Why Is Pfizer Stock Trading Lower Today After Dropping Obesity Candidate Data? - Pfizer (NYSE:PFE)

Pfizer Inc (NYSE: PFE) reported topline data from the Phase 2b trial investigating its oral weight loss drug Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes.